Patient P13 was particularly informative for analyzing the clonal evolution of ALK mutations in neuroblastoma, as tumor material of six different timepoints was available for monitoring allelic fractions over the course of disease by ddPCR (Fig. 6b). This evidence concerns the gene ALK and neoplasm.